Location History:
- Berlin, DE (2014 - 2018)
- Stanford, CA (US) (2019)
- Mountain View, CA (US) (2018 - 2023)
Company Filing History:
Years Active: 2014-2023
Title: Innovations of Andre Berndt
Introduction
Andre Berndt is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of light-responsive polypeptides. With a total of eight patents to his name, Berndt's work is at the forefront of optogenetics and cellular control.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Light-responsive polypeptides and methods of use thereof." This patent provides variant light-responsive polypeptides and nucleic acids that encode these polypeptides. The disclosure includes methods, devices, and systems for controlling the activity of cells that express these innovative polypeptides. Another notable patent is for "Engineered light-activated anion channel proteins and methods of use thereof." This invention encompasses compositions, devices, systems, and methods for the optogenetic modulation of action potentials in target cells. The devices described include light-generating and control devices that deliver light-responsive polypeptides or nucleic acids to target cells, facilitating the manipulation of action potentials for potential therapeutic applications.
Career Highlights
Andre Berndt is affiliated with Leland Stanford Junior University, where he continues to advance his research in the field of optogenetics. His work has garnered attention for its potential applications in treating neurological and psychiatric conditions in both human and animal subjects.
Collaborations
Berndt has collaborated with notable researchers in his field, including Karl A. Deisseroth and Ofer Yizhar. These collaborations have further enhanced the impact of his research and innovations.
Conclusion
Andre Berndt's contributions to the field of biotechnology through his patents and research are paving the way for new therapeutic approaches in medicine. His innovative work in light-responsive polypeptides exemplifies the potential of optogenetics in advancing our understanding and treatment of complex conditions.